Allogene secures commitment for $250mm through ATM

14:40 EST 8 Nov 2019 | Elsevier Business Intelligence

Allogene Therapeutics Inc. (allogeneic cell therapies for cancer) secured a commitment for a $250mm at-the-market investment ...

Original Article: Allogene secures commitment for $250mm through ATM


More From BioPortfolio on "Allogene secures commitment for $250mm through ATM"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...